Update On Long-Acting Interferons For Mpn

Update on Long-acting Interferons for MPN

Update on Long-acting Interferons for MPN

Development of long-acting interferon as new therapy for PV and ET

Long-acting interferon: What is the difference?

The use of interferons in the treatment of MPNs

VJHemOnc – Video Journal of Hematology & HemOnc

Current therapy options and clinical outcomes analysis in patients with PV

Management of PV, the role of interferon

The MPN Interferon Initiative

MPN Research Foundation

Management of PV, The Role of Interferon

PROUD-PV/CONTINUATION-PV studies: benefits of ropeg IFN alfa-2b for the treatment of PV

Interim results of pegylated interferon alpha-2a for polycythemia vera and essential thrombocythemia

VJHemOnc – Video Journal of Hematology & HemOnc

Interferons: a promising potential therapy for MPN

VJHemOnc – Video Journal of Hematology & HemOnc

Clinical updates on the use of ropeginterferon for polycythemia vera

VJHemOnc – Video Journal of Hematology & HemOnc

A Conversation with an MPN Specialist: Interferon: Why and How it Works in MPN Patients

MPN Advocacy & Education International

10 facts MPN patients need to know about FDA approval of Ropegylated interferon alpha2b (Besremi).

UT Health San Antonio MD Anderson Cancer Center

Pegylated interferon for the treatment of polycythemia vera and essential thrombocythemia

VJHemOnc – Video Journal of Hematology & HemOnc

Conversation with an MPN Specialist: Summer Updates

MPN Advocacy & Education International

Update on the use of interferon-alfa for polycythemia vera

VJHemOnc – Video Journal of Hematology & HemOnc

Dr Raajit Rampal-Interferon and New MPN Therapies

MPN Advocacy & Education International

Determining when to switch from hydroxyurea to interferon-based therapy in patients with PV

VJHemOnc – Video Journal of Hematology & HemOnc